NEWMARK

BGC's Lutnick Targets Fourth Quarter for Spin-Off of Newly Rebranded Newmark as Separate Publicly Traded Company

Written By Randyl Drummer | CoStar

Howard Lutnick, chairman and chief executive of Newmark parent company BGC Partners, Inc., (Nasdaq: BGCP), this week said he expects the planned spin-off of Newmark as a separate publicly traded company to occur in the fourth quarter.

"We would like to do the initial public offering of Newmark in this calendar year," Lutnick said this afternoon during a presentation at the Sandler O'Neill + Partners Global Exchange & Brokerage Conference in New York City.

"You can assume that's not going to be the summer because it's unlikely we'll take a company public in August, and we're not going to do it at Christmas. Somewhere in late September, October, November would be the kind of time frame we're looking at."

Lutnick said NKF, which dropped the Grubb name from its logo and other branding on its web site and press materials over the weekend, said the company will probably be called simply Newmark by the time the spin off occurs. On Tuesday, Newmark public relations representatives confirmed the return to Newmark, its corporate name before Newmark acquired Grubb & Ellis in April 2012 and rebranded as Newmark Grubb Knight Frank (NGKF).

"We had Grubb, and we'll probably simplify the name. There's (still) too many names in there," Lutnick told analysts at the conference, which is primarily a spotlight for the publicly traded electronic bulletin board trading group that is the core business of BGC and its largest shareholder, investment bank Cantor Fitzgerald & Co.

Continue Reading Article

temp-post-image

All information contained in this publication is derived from sources that are deemed to be reliable. However, Newmark has not verified any such information, and the same constitutes the statements and representations only of the source thereof, and not of Newmark. Any recipient of this publication should independently verify such information and all other information that may be material to any decision that recipient may make in response to this publication, and should consult with professionals of the recipient's choice with regard to all aspects of that decision, including its legal, financial, and tax aspects and implications. Any recipient of this publication may not, without the prior written approval of Newmark, distribute, disseminate, publish, transmit, copy, broadcast, upload, download, or in any other way reproduce this publication or any of the information it contains. This document is intended for informational purposes only and none of the content is intended to advise or otherwise recommend a specific strategy. It is not to be relied upon in any way to predict market movement, investment in securities, transactions, investment strategies or any other matter.

Download Our
Brochure

Sign Up for Our Newsletter

VIEW 2022 HEALTHCARE OUTLOOK